최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of nutrition and health, v.46 no.6, 2013년, pp.511 - 520
Monocyte chemoattractant protein-1 (MCP-1) plays an important role in cardiovascular disease (CVD). Genetic polymorphism in the regulatory regions of MCP-1 could affect MCP-1 expression. The purpose of the study was to explore the possible association of MCP-1 -2518 A/G genetic polymorphism and CVD ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
심혈관계질환의 특징은? | 심혈관계질환은 전 세계적으로 건강을 위협하는 문제 중의 하나이며, 국내의 경우도 심혈관질환은 사망의 주요 원인이며 심혈관계질환과 관련된 노인의 사망률은 21%로 보고된바 있다.1)심혈관계질환은 만성 염증 반응이 질환 발생의 중요한 기전으로 설명되고 있고,2) 만성염증반응을 유발하고 유지하는 중요한 인자 가운데 하나가 사이토카인이다. | |
심혈관계질환 발생의 주요 기전은? | 심혈관계질환은 전 세계적으로 건강을 위협하는 문제 중의 하나이며, 국내의 경우도 심혈관질환은 사망의 주요 원인이며 심혈관계질환과 관련된 노인의 사망률은 21%로 보고된바 있다.1)심혈관계질환은 만성 염증 반응이 질환 발생의 중요한 기전으로 설명되고 있고,2) 만성염증반응을 유발하고 유지하는 중요한 인자 가운데 하나가 사이토카인이다. 케모카인은 사이토카인의 일종으로 조직의 염증 반응 시 혈중 세포를 활성화시켜서 활성화된 세포들이 혈관내피세포에 결착하고, 백혈구 세포들을 이동시켜 염증 반응을 유도하게 된다. | |
식이 섭취 패턴이 심혈관계질환과 가지는 관계에 대한 연구는 어떤 것들이 있는가? | 식이 섭취 패턴은 심혈관계질환의 예방이나 치료에 중요한 역할을 한다.20-24) 포화지방산의 섭취량이 증가할수록 심혈관계질환의 발병률을 높아지고, 식물성 유지와 불포화지방산의 섭취량은 동물성 유지와 포화지방산의 섭취에 비해 심혈관계 질환의 위험도를 감소시킨다고 보고되었다. 21) 또한 포화지방산의 섭취량을 감소시키면 심혈관계질환 발병률도 감소되며, 지중해식 식사 (고식이섬유, 올리브유함유, 생선함유, 지방섭취 비율 30% 미만)는 심혈관계질환에서의 생존율을 증가시키는 것으로 보고되었다.22) 심혈관계질환과 식이섭취와의 관련성은 많은 연구를 통해 이미 보고되었으나, 식이 섭취 패턴이 심혈관계질환의 위험 인자 중 MCP-1의 혈중 수준에 미치는 영향에 대한 연구는 미미하며, MCP-1 유전자 다형성에 따른 식이 섭취 영향을 본 연구는 전무한 실정이다. |
Statistics Korea. Deaths and death rates. In: The Cause of Death Statistics 2011. Seoul: Statistics Korea; 2012. p.3
Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005; 46(11): 1978-1985
Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147(2): 213-225
Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009; 41(5): 998-1001
Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991; 88(12): 5252-5256
Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88(4): 1121-1127
Seli E, Pehlivan T, Selam B, Garcia-Velasco JA, Arici A. Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril 2002; 77(3): 542-547
de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003; 107(5): 690-695
Serrano-Martinez M, Palacios M, Lezaun R. Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease. Circulation 2003; 108(10): e75
Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21(3): 327- 334
Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004; 44(9): 1812-1818
Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP- 1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259(2): 344-348
Kroner A, Maurer M, Loserth S, Kleinschnitz C, Hemmer B, Rosche B, Toyka KV, Rieckmann P. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis. Tissue Antigens 2004; 64(1): 70-73
Kruger B, Schroppel B, Ashkan R, Marder B, Zulke C, Murphy B, Kramer BK, Fischereder M. A monocyte chemoattractant protein- 1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002; 13(10): 2585-2589
Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L, Csaszar A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158(1): 233-239
Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I, Miki T. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003; 26(9): 677-683
Buraczynska M, Bednarek-Skublewska A, Buraczynska K, Ksiazek A. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Cytokine 2008; 44(3): 361-365
Jeon HJ, Choi HJ, Park BH, Lee YH, Oh T. Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes. Yonsei Med J 2013; 54(3): 621-625
Moon JY, Jeong L, Lee S, Jeong K, Lee T, Ihm CG, Suh J, Kim J, Jung YY, Chung JH. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 2007; 22(5): 810-814
Stang J, Zephier EM, Story M, Himes JH, Yeh JL, Welty T, Howard BV. Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: the Strong Heart Dietary Study, Phase II. J Am Diet Assoc 2005; 105(12): 1895-1903
Tell GS, Evans GW, Folsom AR, Shimakawa T, Carpenter MA, Heiss G. Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1994; 139(10): 979-989
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99(6): 779- 785
Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 2005; 81(1): 189-195
Jiang R, Jacobs DR Jr, Mayer-Davis E, Szklo M, Herrington D, Jenny NS, Kronmal R, Barr RG. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006; 163(3): 222-231
Park HJ. Association of MCP-1 polymorphism with cardiovascular risk factors in Korean elderly [Ph.D. thesis]. Seoul: Ewha Womans University; 2007
The Korean Nutrition Society, Korean Nutrition Information Center. Nutritional assessment program, 'CAN pro 3.0' [CDROM]. Seoul: The Korean Nutrition Society; 2006
The Korean Nutrition Society. Dietary reference intakes for Koreans. Seoul: The Korean Nutrition Society; 2010
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502
Kitamoto S, Egashira K. Anti-monocyte chemoattractant protein- 1 gene therapy for cardiovascular diseases. Expert Rev Cardiovasc Ther 2003; 1(3): 393-400
Okopie? B, Haberka M, Cwalina L, Kowalski J, Belowski D, Madej A, Zieli?ski M, Krysiak R, Labuzek K, Kalina Z, Herman ZS. Plasma cytokines as predictors of coronary heart disease. Res Commun Mol Pathol Pharmacol 2002; 112(1-4): 5-15
Ozyurek AR, Gurses D, Ulger Z, Levent E, Bakiler AR, Berdeli A. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clin Rheumatol 2007; 26(4): 546- 550
Kim HL, Yang SH, Oh YK, Lee JE, Oh JE, Yoon HJ, Kim YS, Ahn CR, Han JS, Kim SG, Lee JS. The effects of polymorphism in the MCP-1 gene regulatory region on MCP-1 expression and the manifestation of lupus nephritis. Korean J Nephrol 2002; 21(1): 137-144
Pae CU, Kim JJ, Yu HS, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH. Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean population. Neuropsychobiology 2004; 49(3): 111-114
Zhong C, Luzhan Z, Genshan M, Jiahong W, Xiaoli Z, Qi Q. Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease. Mol Biol Rep 2010; 37(1): 7-12
Pola R, Flex A, Gaetani E, Proia AS, Papaleo P, Di Giorgio A, Straface G, Pecorini G, Serricchio M, Pola P. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004; 39(8): 1249- 1252
Zietz B, Buchler C, Herfarth H, Muller-Ladner U, Spiegel D, Scholmerich J, Schaffler A. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism. Diabetes Obes Metab 2005; 7(5): 570-578
Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez- Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58(5): 335-338
Penz P, Bucova M, Lietava J, Blazicek P, Paulovicova E, Mrazek F, Bernadic M, Buckingham TA, Petrek M. MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects. Bratisl Lek Listy 2010; 111 (8): 420-425
Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D'Agostino R, Meigs JB, Ordovas J, Cobain M, Millen B. Dietary patterns and the metabolic syndrome in obese and nonobese Framingham women. Obes Res 2005; 13(1): 153-162
Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25(1): 148-198
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337 (21): 1491-1499
Shishehbor F, Roche HM, Gibney MJ. The effect of low and moderate fat intakes on the postprandial lipaemic and hormonal responses in healthy volunteers. Br J Nutr 1999; 81(1): 25-30
German JB. Genetic dietetics: nutrigenomics and the future of dietetics practice. J Am Diet Assoc 2005; 105(4): 530-531
Tanasescu M, Cho E, Manson JE, Hu FB. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr 2004; 79(6): 999-1005
※ AI-Helper는 부적절한 답변을 할 수 있습니다.